{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:58:08Z","timestamp":1792173488221,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013669","name":"Ionis Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jaip.2025.06.018","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T03:53:47Z","timestamp":1752724427000},"page":"2381-2389.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Donidalorsen Treatment of Hereditary Angioedema in Patients Previously on Long-Term Prophylaxis"],"prefix":"10.1016","volume":"13","author":[{"given":"Marc A.","family":"Riedl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleena","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Perego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Lumry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. James","family":"Wedner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Gierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bordone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Treadwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth B.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Yarlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9036-3723","authenticated-orcid":false,"given":"Danny M.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.06.018_bib1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaip.2023.12.025","article-title":"Clinical progress in hepatic targeting for novel prophylactic therapies in hereditary angioedema","volume":"12","author":"Riedl","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.06.018_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaip.2020.08.046","article-title":"US HAEA Medical Advisory Board 2020 Guidelines for the management of hereditary angioedema","volume":"9","author":"Busse","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.06.018_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13223-021-00537-2","article-title":"Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report","volume":"17","author":"Bork","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.018_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2023.100792","article-title":"The multifactorial impact of receiving a hereditary angioedema diagnosis","volume":"16","author":"Raasch","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2025.06.018_bib5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s12325-022-02401-0","article-title":"Hereditary angioedema: diagnosis, clinical implications, and pathophysiology","volume":"40","author":"Sinnathamby","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2025.06.018_bib6","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s13555-021-00593-x","article-title":"Recognition and management of hereditary angioedema: best practices for dermatologists","volume":"11","author":"Manning","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaip.2025.06.018_bib7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaci.2020.10.015","article-title":"Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase 3 trial","volume":"148","author":"Zuraw","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.018_bib8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.anai.2020.02.018","article-title":"Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States","volume":"124","author":"Banerji","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.06.018_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13223-023-00795-2","article-title":"A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis","volume":"19","author":"Mendivil","year":"2023","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.018_bib10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2500\/aap.2022.43.220046","article-title":"Long-term prophylaxis in hereditary angioedema management: current practices in France and unmet needs","volume":"43","author":"Bouillet","year":"2022","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2025.06.018_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100627","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema - the 2021 revision and update","volume":"15","author":"Maurer","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2025.06.018_bib12","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1001\/jama.2018.16773","article-title":"Effect of lanadelumab compared with placebo on prevention of hereditary angioedema attacks: a randomized clinical trial","volume":"320","author":"Banerji","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2025.06.018_bib13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1613627","article-title":"Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor","volume":"376","author":"Longhurst","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.06.018_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12243","article-title":"Current challenges and future opportunities in patient-focused management of hereditary angioedema: a narrative review","volume":"13","author":"Grumach","year":"2023","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2025.06.018_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/nat.2018.0754","article-title":"IONIS-PKK","volume":"29","author":"Ferrone","year":"2019","journal-title":"Nucleic Acid Ther"},{"key":"10.1016\/j.jaip.2025.06.018_bib16","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1056\/NEJMoa2109329","article-title":"Inhibition of prekallikrein for hereditary angioedema","volume":"386","author":"Fijen","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.06.018_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa2402478","article-title":"Efficacy and safety of donidalorsen for hereditary angioedema","volume":"391","author":"Riedl","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.06.018_bib18","series-title":"Full prescribing information","year":"2023"},{"key":"10.1016\/j.jaip.2025.06.018_bib19","series-title":"Full prescribing information","year":"2022"},{"key":"10.1016\/j.jaip.2025.06.018_bib20","series-title":"Full prescribing information","year":"2022"},{"key":"10.1016\/j.jaip.2025.06.018_bib21","series-title":"Full prescribing information","year":"2024"},{"key":"10.1016\/j.jaip.2025.06.018_bib22","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/all.12007","article-title":"Development and construct validation of the angioedema quality of life questionnaire","volume":"67","author":"Weller","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.06.018_bib26","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jaip.2020.02.038","article-title":"Validation of the Angioedema Control Test (AECT)-a patient-reported outcome instrument for assessing angioedema control","volume":"8","author":"Weller","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.06.018_bib24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/all.14144","article-title":"Development of the Angioedema Control Test-a patient-reported outcome measure that assesses disease control in patients with recurrent angioedema","volume":"75","author":"Weller","year":"2020","journal-title":"Allergy"},{"issue":"suppl 1","key":"10.1016\/j.jaip.2025.06.018_bib27","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1111\/j.1524-4733.2005.00066.x","article-title":"Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers","volume":"8","author":"Atkinson","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.jaip.2025.06.018_bib23","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/all.12900","article-title":"The Angioedema Quality of Life Questionnaire (AE-QoL) - assessment of sensitivity to change and minimal clinically important difference","volume":"71","author":"Weller","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.06.018_bib28","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1915035","article-title":"Antisense inhibition of prekallikrein to control hereditary angioedema","volume":"383","author":"Cohn","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.06.018_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-041217-010829","article-title":"Therapeutic antisense oligonucleotides are coming of age","volume":"70","author":"Bennett","year":"2019","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaip.2025.06.018_bib30","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ymthe.2020.06.015","article-title":"Delivery of oligonucleotides to the liver with GalNAc: from research to registered therapeutic drug","volume":"28","author":"Debacker","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaip.2025.06.018_bib31","article-title":"Patient preferences for attributes of prophylactic treatment in hereditary angioedema: a discrete-choice experiment. Poster presented at the American Academy of Allergy","author":"Villa","year":"2025","journal-title":"Asthma, and Immunology\/World Allergy Organization Joint Congress"},{"key":"10.1016\/j.jaip.2025.06.018_bib32","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/nar\/gky060","article-title":"Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins","volume":"46","author":"Shen","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaip.2025.06.018_bib33","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.ymthe.2017.06.002","article-title":"RNase H1-Dependent antisense oligonucleotides are robustly active in directing RNA cleavage in both the cytoplasm and the nucleus","volume":"25","author":"Liang","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaip.2025.06.018_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","article-title":"RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform","volume":"50","author":"Bennett","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jaip.2025.06.018_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2500\/aap.2021.42.200106","article-title":"Androgen use in hereditary angioedema: a critical appraisal and approaches to transitioning from androgens to other therapies","volume":"42","author":"Johnston","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2025.06.018_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13223-021-00644-0","article-title":"Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series","volume":"18","author":"Maurer","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.018_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jval.2014.10.007","article-title":"Measuring change in quality of life: bias in prospective and retrospective evaluation","volume":"18","author":"Blome","year":"2015","journal-title":"Value Health"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825005999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825005999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:55:13Z","timestamp":1777625713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825005999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2213219825005999"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.06.018","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donidalorsen Treatment of Hereditary Angioedema in Patients Previously on Long-Term Prophylaxis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}